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Abstract
Background Given the much greater COVID-19
mortality risk experienced by people with intellectual
disabilities (ID), understanding the willingness of
people with ID to take a COVID-19 vaccine is a major
public health issue.
Method In December 2020 to February 2021, across
the United Kingdom, 621 adults with ID were
interviewed remotely and 348 family carers or support
workers of adults with ID with greater needs com-
pleted an online survey, including a question on will-
ingness to take a COVID-19 vaccine if offered.
Results Eighty-seven per cent of interviewees with
ID were willing to take a COVID-19 vaccine, with
willingness associated with white ethnicity, having
already had a flu vaccine, gaining information about
COVID-19 from television but not from social
media, and knowing COVID-19 social restrictions
rules. A percentage of 81.7% of surveyed carers of
adults with ID with greater needs reported that the
person would be willing to take a COVID-19
vaccine, with willingness associated with white
ethnicity, having a health condition of concern in
the context of COVID-19, having had a flu vaccine,
being close to someone who had died due to
COVID-19, and having shielded at some point
during the pandemic.
Conclusions Reported willingness to take the
COVID-19 vaccine is high among adults with ID in
the United Kingdom, with factors associated with
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willingness having clear implications for public health
policy and practice.
Keywords COVID-19, intellectual disability,
United Kingdom, vaccine willingness
Introduction
Willingness to take vaccines (or in the negative –
vaccine ‘hesitancy’) has long been a topic of research
in public health and has become especially significant
in the context of the current COVID-19 pandemic,
leading to multiple research studies internationally
(for reviews, refer to Lin et al. 2020; Sallam 2021).
Large within and across-nation general population
surveys of adults have been carried out since early in
the COVID-19 pandemic (i.e. from as early as March
2020). These research studies have generally found:
considerable variability in willingness to accept a
COVID-19 vaccine across countries (Kerr et al. 2020;
Lazarus et al. 2020); reducing willingness from the
beginning of, or early in, the pandemic to the end of
2020 (Kerr et al. 2020; Lin et al. 2020); and that
correlates of vaccine willingness/hesitancy vary across
populations and countries (Lazarus et al. 2020).
People with intellectual disabilities (ID) have been
shown to be at considerably increased risk for
COVID-19 infection and mortality following
COVID-19 infection compared with adults without
ID (Clift et al. 2020; Gleason et al. 2021; Henderson
et al. 2021; Williamson et al. 2021). The
subpopulation of individuals with Down syndrome
may be particularly vulnerable, potentially due to
increased risks of immune dysregulation, congenital
heart disease and respiratory conditions (Clift
et al. 2020; Dard et al. 2020). Given such findings,
and the underlying health inequities experienced by
people with ID (Emerson and Hatton 2013), there
have been calls internationally for people with ID to
be prioritised for vaccines (e.g. Hotez et al. 2021).
Countries including the United Kingdom
(DHSC 2021) have acted in response to such calls,
and the emerging data, to include people with ID in
vaccine priority groups.
In this context, understanding vaccine willingness
among populations of people with ID is crucial to
inform national and potentially international public
health policy, particularly as there is some evidence
that people with ID can be fearful of a range of
medical procedures, including needle phobia
(Marriott 2017; Kupzyk and Allen 2019). In addition,
there is not a tradition of vaccine hesitancy in
developmental disabilities research, except notably to
understand views about vaccines in parents of autistic
children (e.g. Goin-Kochel et al. 2020). As yet, there
are also few data available about COVID-19 vaccine
willingness and people with ID. Lunsky et al. (2021)
gathered data from 3371 workers in developmental
disability services in Ontario, Canada, in early 2021
asking them about their own willingness to take the
vaccine. The majority (62% very likely, a further 20%
likely) reported that they would likely take the vaccine
when offered. Given the importance of protecting in-
dividuals with ID, especially within residential set-
tings (Landes et al. 2020), the Lunsky et al. study
provided useful data to inform educational initiatives
to increase vaccine uptake among paid care workers.
Factors associated with non-intent to have a
COVID-19 vaccine were: being younger, and en-
dorsing beliefs about the lack of vaccine benefits,
worry about rapid development of the vaccine, and
concerns about side effects (Lunsky et al. 2021).
We could find only one study with any data from
people with ID themselves. In a survey of family
carers, paid staff, and people with intellectual and
developmental disabilities in New York State, USA,
Iadarola et al. (2021) reported data on vaccine
willingness from 91 people with disabilities
(including people with ID). ‘Vaccine intent’ was
defined as definitely or probably being willing to
have the vaccine and included a small number of
people who had already had a vaccine, with 83.5%
reporting positive vaccine intent. Correlates of
vaccine intent were not examined separately for the
group of disabled people responding directly to the
survey.
Given variability in vaccine willingness across
countries, variability in correlates of vaccine intent
across countries, and the lack of data about vaccine
willingness directly from or about individuals with ID,
additional country-specific data are needed urgently
to inform vaccine policy. In the current study, we
report data about willingness to take a COVID-19
vaccine from:
1 adults with ID across the four UK countries
(England, Northern Ireland, Scotland and Wales)
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who could take part in a remotely conducted in-
terview (e.g. via videolink or telephone)
2 carers of adults with ID who were not able to take
part in a direct interview with researchers.
For both samples, we report factors associated with
willingness to take the COVID-19 vaccine.
Methods
Participants
Two samples were recruited: adults with ID who were
interviewed by a researcher (Cohort 1), and adults
with ID who would not be able to take part in an
interview, where family carers and support workers
reported via an online survey (Cohort 2). Full details
of the survey methods and participants can be found
in Flynn et al. (2021).
Selected demographic information is presented in
Table 1 for both cohorts. For Cohort 1, most of the
participants were aged 16–44 years (68.2%), just over
half were men (51.3%), the vast majority were white
(94.7%), and 11% were people with Down syndrome.
Substantial proportions of participants in Cohort 1
were living with their family (41.4%), living alone or
with a partner (36.3%) or living with other people with
ID in some form of supported housing or residential
accommodation (22.3%). For Cohort 2, most people
with ID were aged 16–45 (80.8%), a majority were
men (56.5%), and the vast majority were white
(94.1%). Almost half were people with ‘Profound and
Multiple Learning (Intellectual) Disabilities’
(44.0%), and 18.3% were people with Down
syndrome. Most adults with ID in Cohort 2 were
living with their family (63.6%), relatively few people
were living alone or with a partner (10.7%), and a
quarter of people were living with other people with
ID in some form of supported housing or residential
accommodation (25.7%).
Measures
Table 1 shows the set of measures used for the
analyses in this paper, including how they were coded
for the purposes of analysis. Responses reported by
small numbers of participants (e.g. participants with a
gender identity other than man or woman) were
collapsed into broader categories or excluded from
the specific analyses involving the relevant variable,
but these participants were included in all other
analyses (e.g. people identifying as a gender other
than male or female were excluded from analyses
concerning gender, but were included in all other
analyses). An empty cell in Table 1 indicates that the
particular measure was not collected with the
particular cohort.
The selection and wording of measures was
finalised through extensive consultation with groups
of people with ID (particularly for Cohort 1
interviews) and family organisations (particularly for
Cohort 2 surveys), to maximise relevance and
accessibility. Where possible, survey items were
adapted from those used in larger UK population
surveys concerning people’s experiences through the
COVID-19 pandemic, such as the Office for National
Statistics Opinions and Lifestyle Survey (ONS 2021)
and the Understanding Society COVID-19 survey
(Understanding Society 2021). A shortened version of
the Pandemic Anxiety Scale (McElroy et al. 2020)
was also used, retaining four of the seven items related
to worries about COVID-19 infection or leaving the
house, and excluding worries about job and financial
prospects.
For the analyses included here, measures included
demographic factors, items related to health and
COVID-19, and (for Cohort 1) items concerning
information and knowledge about COVID-19
restrictions and anxiety related to the pandemic.
Procedure
Recruitment of people into the study was facilitated
through multiple methods across the United
Kingdom, including through collaborating organisa-
tions in each country, social media, and wider net-
works of ID and family organisations across England,
Northern Ireland, Scotland and Wales. Potential
participants could express interest in the study via
telephone, e-mail, social media or clicking a link to
the survey (for family carers and support staff only) on
the research project website. Contact details of people
who had indicated an interest in taking part in Cohort
1 were sent to research teams in each country, who
contacted each person to talk through the project and
send them the easy read participant information
sheet. If people were still interested in taking part, at
least 24 h later, the interviewer arranged to go through
the consent process and, if the person consented,
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16–44 n = 416 (68.2%) n = 291 (80.8%)
45+ n = 194 (31.2%) n = 69 (18.3%)
Gender
Male n = 312 (51.3%) n = 204 (56.5%)
Female n = 296 (48.7%) n = 157 (43.5%)
Ethnicity
White White n = 588
(94.7%)
White n = 348 (94.1%)
All other groups Other ethnic group
n = 33 (5.3%)
Other ethnic group
n = 22 (5.9%)
Person with Profound Multiple Learning Disabilities (PMLD) Data not collected
Yes n = 164 (44.0%)
Not sure/No n = 209 (56.0%)
Down syndrome
Yes n = 67 (11.0%) n = 68 (18.3%)
No n = 540 (89.0%) n = 304 (81.7%)
Living situation
Living with family n = 247 (41.4%) n = 213 (63.6%)
Living alone/with partner n = 217 (36.3%) n = 36 (10.7%)
Living with other people with intellectual disabilities n = 133 (22.3%) n = 86 (25.7%)
Health-related variables
Willingness to take the COVID-19 vaccine if offered
Yes n = 474 (87.0%) n = 267 (80.9%)
Not sure/No n = 71 (13.0%) n = 63 (19.1%)
Health condition that is a worry if the person gets coronavirus
Yes n = 315 (51.6%) n = 245 (70.2%)
No n = 295 (48.4%) n = 104 (29.8%)
Self or carer rated health of the person today
Good n = 367 (60.1%) n = 193 (53.0%)
OK n = 205 (33.6%) n = 133 (36.5%)
Not very good n = 39 (6.4%) n = 38 (10.4%)
Currently taking medications
Yes n = 477 (78.1%) n = 290 (81.0%)
No n = 134 (21.9%) n = 68 (19.0%)
Has had flu vaccine in 2020/21 winter flu season
Yes n = 403 (66.3%) n = 253 (72.5%)
No n = 183 (30.1%) n = 61 (17.5%)
Do not want a flu jab n = 22 (3.6%) n = 35 (10.0%)
Has shielded at any time since first lockdown
Yes n = 193 (31.3%) n = 215 (59.6%)
No n = 423 (68.7%) n = 146 (40.4%)
Family member/friend/someone close to the person has died due
to COVID-19
Yes n = 98 (15.9%) n = 29 (7.8%)
No n = 499 (81.0%) n = 327 (87.9%)
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conduct the interview. For Cohort 2, the survey was
available online, and included extensive participant
information and consent questions before the survey
started. No participants received an honorarium for
participating.
For both cohorts, data were collected from
mid-December 2020 to the end of February 2021.
Unconnected to this study, national announcements
about all adults with ID being prioritised for
COVID-19 vaccines were made across the United
Kingdom in the final week of February 2021.
For Cohort 1, trained research interviewers directly
interviewed adults with ID via Zoom, telephone,
Microsoft Teams, WhatsApp video call, Messenger
video call or FaceTime, depending on the
interviewee’s preference. All interviewees had the
capacity to take part in the interviews and gave their
consent to do so before the interview was conducted.
Data were entered directly into Qualtrics™ during the
interviews by the interviewers. Three people preferred
to self-complete an online version of the survey, and
in these cases, this was made available to them at their
request. Participants were also able to have a
supporter of their choice (e.g. family member and
support staff) present at the interview. In all cases,
flexibility was paramount to ensure that people with
ID were able to participate in their preferred way.
Interviews took typically 45 min to complete, and
were usually completed in one sitting. Short breaks
were offered during interviews when needed. All
interviewers had experience of research interviewing
and were trained via online training sessions within
each country, with additional training sessions across













Information and knowledge of COVID-19 rules
Person’s sources of information about COVID-19 rules Data not collected
Talking to friends/family n = 274 (44.1%)
Talking to support worker n = 227 (36.6%)
Television n = 490 (78.9%)
Radio n = 96 (15.5%)
Social media n = 153 (24.6%)
Newspapers n = 39 (6.3%)
Government website n = 76 (12.2%)
Phone news app n = 86 (13.8%)
Easy for person to find good information about COVID-19 Data not collected
Yes n = 427 (69.5%)
No n = 187 (30.5%)
Person knows rules where the person lives about
COVID-19 restrictions
Data not collected
Yes n = 521 (84.7%)
Not sure/No n = 187 (30.5%)
Pandemic anxiety
Pandemic Anxiety Scale (McElroy et al. 2020). Mean score
(1 = Not at all worries; 2 = A little worried; 3 = Worried a lot)
for 4 health-related items: I am worried that I will catch coronavirus;
I am worried that family and friends will catch coronavirus; I’m
worried to leave my home right now; I’m worried I might
give the infection to someone else. Excluded if 2 or more missing
items from these 4.
Mean item score 1.99
(SD 0.61)
Data not collected
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interviewers. Of those who consented to be
interviewed, 86% (n = 545) answered the question on
vaccine hesitancy.
For Cohort 2, information was collected via an
online Qualtrics™ survey about adults with ID who
were not able to take part in an interview with a
researcher. To gather data on this group, we surveyed
their family carers or paid support staff. Eighty-three
per cent of participants were family carers of an adult
with ID, and 15% of participants were paid support
staff of an adult with ID. The remaining 3% of
participants were other people who knew the adult
with ID very well (e.g. a friend).
Data analysis
Cohorts 1 and 2 data sets were analysed separately
throughout, using SPSS 26. For categorical variables,
potential associations between willingness to take a
COVID-19 vaccine were analysed using Fisher’s
exact test (for 2 × 2 tables) or chi-square (for 3 × 2
tables), and relative risk (RR) (with 95% confidence
intervals) for all comparisons. For mean scores on the
four items taken from the Pandemic Anxiety Scale
(McElroy et al. 2020), a t-test (with Cohen’s d to
evaluate effect size) was conducted between those
willing or unwilling to take the COVID-19 vaccine.
All tests were two-sided or two-tailed.
Ethical approval
Research ethics approval was sought and obtained
from the Manchester Metropolitan University Faculty
of Health, Psychology and Social Care Faculty
Research Ethics Committee.
Data availability
A quantitative data set will be archived online in a
form that will be available to researchers after all
waves of data collection for the project have been
completed.
Results
Cohort 1 – interviews with adults with intellectual
disabilities
The vast majority of adults with ID interviewed
(87.0%; n = 474) said that they would take a
coronavirus vaccine if they were offered one, with
8.4% (n = 46) saying they were not sure, and 4.6%
(n = 25) saying they would not take the vaccine.
Table 2 first presents potential associations
between demographic factors and willingness to take
a COVID-19 vaccine. The only statistically significant
association concerned ethnicity (Fisher’s exact
P = 0.033), with people in white ethnic groups 22%
more likely (RR 1.22) to be willing to take a
COVID-19 vaccine if it was offered, although the 95%
confidence interval for RR did contain 1, indicating
that the two groups may not be distinct in their
vaccine willingness.
Table 2 also presents potential associations
between health-related factors and willingness to take
a COVID-19 vaccine. There was a statistically
significant association with people having had a flu
vaccine in the 2020/21 winter flu season (Fisher’s
exact P < 0.001): people who had had a flu vaccine
were 19%more likely (RR = 1.19) to be willing to take
a COVID-19 vaccine than people who had not or did
not want a flu vaccine.
In terms of factors related to information and
knowledge about coronavirus and social distancing
rules, Table 2 reports that two information sources
were associated with willingness to take a
COVID-19 vaccine. People who got information
about coronavirus from the television were 15%
more likely to be willing to take a COVID-19
vaccine (Fisher’s exact P = 0.002; RR = 1.15), and
people who got information from social media were
12% less likely to be willing to take a COVID-19
vaccine (Fisher’s exact P = 0.003; RR = 0.88).
People who said they knew the social distancing
rules where they lived were also 14% more likely to
be willing to take a COVID-19 vaccine (Fisher’s
exact P = 0.013; RR = 1.14).
Finally, Table 2 shows there was no evidence of a
difference in shortened Pandemic Anxiety Scale mean
scores between those who would be willing to take a
COVID-19 vaccine and those who were not sure or
would not be willing to take a vaccine (t = 1.84;
df = 533; P = 0.067 (two-tailed); Cohen’s d = 0.25).
Cohort 2 – survey of carers (including paid support
staff) of adults with intellectual disabilities
The vast majority of carers of adults with ID surveyed
reported that the person they care for would take a
coronavirus vaccine if they were offered it (81.7%;
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Table 2 Factors potentially associated with willingness to take the COVID-19 vaccine: Cohort 1
Willingness to take COVID-19 vaccine: Yes vs. Not Sure/No




(two-sided P) Relative risk (95% CIs)
Demographic variables
Age
16–44 321 (85.6%) P = 0.164 0.95 (0.89–1.01)
45+ 149 (90.3%)
Gender P = 0.606 0.98 (0.92–1.05)
Man 233 (86.3%)
Woman 236 (88.1%)
Ethnicity P = 0.033 1.22 (0.95–1.56)
White 456 (87.7%)
All other groups 18 (72.0%)




Living with family 199 (85.4%) Chi-square = 0.601;
df = 2; P = 0.740
RR Family vs. Others
0.98 (0.91–1.05)
Living alone/with partner 169 (87.1%) RR Alone/Partner vs.
Others 1.01 (0.94–1.08)
Living with other people
with intellectual disabilities
91 (88.3%) RR Other People with
Intellectual disabilities vs.
All Others 1.03 (0.47–1.51)
Health-related variables
Health condition that makes person worry about having coronavirus
Yes 232 (86.2%) P = 0.610 0.98 (0.92–1.05)
No 239 (87.9%)
Self-rated health
Good 281 (86.2%) P = 0.605 0.98 (0.92–1.05)
OK/Not very good 189 (87.9%)
Currently taking medications
Yes 367 (88.4%) P = 0.070 1.08 (0.99–1.18)
No 104 (81.9%)
Has had a flu vaccine in 20/21
Yes 319 (92.2%) P < 0.001 1.19 (1.1–1.3)
No/Do not want a flu jab 150 (77.7%)
Person has shielded
Yes 149 (88.2%) P = 0.680 1.02 (0.95–1.09)
No 325 (86.4%)
Family member/friend has died due to COVID-19
Yes 71 (84.5%) P = 0.477 0.97 (0.88–1.06)
No 388 (87.6%)
Sources of information about coronavirus
Talking to friends/family
Yes 220 (86.6%) P = 0.899 0.99 (0.93–1.06)
No 254 (87.3%)
Talking to support worker
Yes 168 (89.4%) P = 0.284 1.04 (0.98–1.11)
No 306 (85.7%)
Television
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n = 259), with 13.2% (n = 42) reporting they were not
sure, and 5.0% (n = 16) reporting that the person
would not take a vaccine.
Table 3 first presents potential associations between
demographic factors and carer reports of the
willingness of the person with ID to take a COVID-19
vaccine. The only statistically significant association
concerned ethnicity (Fisher’s exact P = 0.043), with
people in white ethnic groups reported to be 30%
more likely (RR 1.30) to be willing to take a
COVID-19 vaccine if it was offered, although the 95%
confidence interval for RR did contain 1.
Table 3 also presents potential associations
between health-related factors and willingness to take
the COVID-19 vaccine. There were four statistically
significant associations.
People with ID were 20% more likely (RR 1.20) to
be reported by carers as willing to take a COVID-19
vaccine if the person had a health condition of concern
if they caught COVID-19, such as epilepsy (Fisher’s
exact P = 0.004). There was also a statistically
significant association with people having had a flu
vaccine in the 2020/21 winter flu season (Fisher’s
exact P < 0.001): people who had had a flu vaccine
were 61% more likely (RR 1.61) to be reported to be
willing to take a COVID-19 vaccine than people who
had not or were reported to not want a flu vaccine.
People with ID were 20% more likely (RR 1.20) to be
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Table 2. (Continued)
Willingness to take COVID-19 vaccine: Yes vs. Not Sure/No




(two-sided P) Relative risk (95% CIs)
Yes 388 (89.4%) P = 0.002 1.15 (1.04–1.28)
No 86 (77.5%)
Radio
Yes 78 (87.6%) P = 1.000 1.01 (0.93–1.10)
No 396 (86.8%)
Social media
Yes 110 (79.1%) P = 0.003 0.88 (0.81–0.97)
No 364 (89.7%)
Newspapers
Yes 29 (93.5%) P = 0.408 1.08 (0.98–1.19)
No 445 (86.6%)
Government website
Yes 64 (87.7%) P = 1.000 1.01 (0.92–1.11)
No 410 (86.9%)
Phone news app
Yes 71 (87.7%) P = 1.000 1.01 (0.92–1.10)
No 403 (86.9%)
Information and rules about coronavirus
Easy to find good information
Yes 328 (87.7%) P = 0.581 1.02 (0.95–1.10)
No 145 (85.8%)
Knows social distancing rules
Yes 410 (88.6%) P = 0.013 1.14 (1.01–1.28)
No 64 (78.0%)
Pandemic anxiety (4 items scored 1 = Not at all worries; 2 = A little worried; 3 = Worried a lot)
Pandemic anxiety Yes to vaccine mean item
score 1.98 (SD 0.62) Not
Sure/No to vaccine mean
item score 2.11 (SD 0.61)
t = 1.84; df = 533;
P = 0.067
Effect size Cohen’s d = 0.25
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reported by carers as willing to take a COVID-19
vaccine if the person had shielded at any point
(Fisher’s exact P = 0.001) during the pandemic up to
the date of the survey. Finally, carer reporting of the
person’s willingness to take the COVID-19 vaccine
was 24% higher (RR 1.24) when carers reported that
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Table 3 Factors potentially associated with willingness to take the COVID-19 vaccine: Cohort 2
Willingness to take COVID-19 vaccine: Yes vs. Not Sure/No
N (%) Yes to COVID
vaccine
Chi-square/Fisher’s exact test
(two-sided P) Relative risk (95% CIs)
Demographic variables concerning the person with intellectual disabilities
Age
16–44 208 (81.3%) P = 0.854 0.97 (0.86–1.10)
45+ 51 (83.6%)
Gender
Man 152 (82.6%) P = 0.662 1.03 (0.93–1.15)
Woman 109 (80.1%)
Ethnicity
White 252 (82.6%) P = 0.043 1.30 (0.94–1.79)
All other groups 14 (63.6%)
PMLD
Yes 119 (83.2%) P = 0.398 1.05 (0.95–1.17)
Not sure/No 148 (79.1%)
Down syndrome
Yes 50 (87.7%) P = 0.194 1.11 (0.99–1.24)
No 216 (79.4%)
Living situation
Living with family 158 (82.3%) Chi-square = 0.578;
df = 2; P = 0.902
RR Family vs. Others
1.04 (0.92–1.17)
Living alone/with partner 26 (78.6%) RR Alone/Partner vs. Others
0.97 (0.80–1.17)
Living with other people with
intellectual disabilities
55 (79.7%) RR Other People with
Intellectual disabilities vs.
All Others 0.98 (0.85–1.12)
Health-related variables
Health condition that carer worries
about if the person gets coronavirus
Yes 186 (85.3%) P = 0.004 1.20 (1.04–1.39)
No 66 (71.0%)
Carer-rated health of person
Good 144 (80.9%) P = 1.000 0.996 (0.90–1.11)
OK/Not very good 121 (81.2%)
Currently taking medications
Yes 207 (81.2%) P = 0.467 0.94 (0.84–1.06)
No 56 (86.2%)
Has had a flu vaccine in 20/21
Yes 204 (91.1%) P < 0.001 1.61 (1.34–1.93)
No/Do not want a flu jab 51 (56.7%)
Person has shielded
Yes 163 (87.6%) P = 0.001 1.20 (1.07–1.34)
No 99 (73.3%)
Someone close to person has died due to COVID-19
Yes 23 (100.0%) P = 0.020 1.24 (1.17–1.31)
No 238 (80.7%)
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someone close to the person with ID had died of
COVID-19 (Fisher’s exact test P = 0.020).
Discussion
Direct comparisons with other UK vaccine
willingness data are not possible given different
timings of data collection and also variations in
phrasing of questions. However, data derived from
the Understanding Society UK panel survey reported
82% vaccine willingness in over 12 000 participants
(Robertson et al. 2021); vaccine acceptance rates in
UK samples repeated from May to October 2020
were consistently above 70% (Kerr et al. 2020); and in
a sample of over 5000 UK adults vaccine acceptance
was 71.7% in September to October 2020 (Freeman
et al. 2020). All these were conducted with general
population samples, and it was not reported if any
data from people with ID were included.
These data suggest that acceptance of COVID-19
vaccination (as reported in the current research) is at
least as high in people with ID, if not slightly higher.
Not only may this be good news given the additional
risks of people with ID to serious consequences of
COVID-19 infection, but it indicates that people with
ID are likely to play their part in COVID-19 public
health programmes. More carers were unsure about
whether people with more significant impairments
would be willing to have a vaccine (Cohort 2) than
people with ID themselves (Cohort 1). However, this
was mainly associated with a perception among
Cohort 2 respondents that suitable supports and
adjustments may not be in place to enable people with
more severe/profound ID and multiple health needs
to receive a vaccine (Flynn et al. 2021).
We did not observe associations between vaccine
willingness and either age or gender; factors that have
been examined extensively with inconsistent findings
in other COVID-19 vaccine willingness research
(Freeman et al. 2020; Kerr et al. 2020; Lazarus
et al. 2020; Robertson et al. 2021). We examined a
number of other demographic factors that may be
associated with vaccine willingness and found the
same association in both cohorts: individuals from
white ethnic groups were more willing to accept
COVID-19 vaccines compared with combined all
other ethnic groups. These findings are similar to
those in other UK samples (Freeman et al. 2020;
Robertson et al. 2021). We did not have sufficient
sample size to examine vaccine willingness in specific
minority ethnic groups, but vaccine hesitancy is
associated in particular with Black and
Pakistani/Bangladeshi communities in other UK
research (Robertson et al. 2021). More recent analysis
of COVID-19 vaccine coverage has found that,
among non-shielding adults with ID aged 16–64,
vaccination rates are considerably lower across black,
mixed, South Asian and other ethnic groups
compared with white groups (OpenSafely 2021).
Future research, therefore, should attempt to examine
more fine-grained analysis of any associations
between ethnicity and vaccine willingness in adults
with ID.
We found no evidence that adults with Down
syndrome were more or less willing to take a
COVID-19 vaccine, and this is encouraging given that
they have been identified as a particularly at risk group
(Clift et al. 2020).
In the current study, health-related factors were
consistently associated with vaccine willingness in
both cohorts of adults with ID. Vaccine willingness
was associated with indicators of health vulnerability in
Cohort 2 (having a health condition of concern in
relation to COVID-19, and having shielded at some
point during the pandemic). Greater willingness in
both cohorts associated with having received a flu
vaccine in the 2020/21 winter season may indicate
experience with vaccination is facilitative for adults
with ID, or that again additional health vulnerability
(and thus need to have a flu vaccine) is associated
with vaccine willingness, or both explanations may be
true. In Cohort 2 (but not Cohort 1), vaccine
willingness was associated with the person being close
to someone who had died of COVID-19.
Finally, for Cohort 1 (questions were not asked for
Cohort 2), getting information about COVID-19
from television bulletins was associated with
increased willingness, getting information from social
media with lower levels of willingness, and reporting
knowing about local pandemic related restrictions
(i.e. being better informed) was associated with
increased willingness.
This study has a number of limitations to be borne
in mind when considering the findings. Participants
identified themselves or people they were caring for or
supporting as people with ID (or ‘learning disabilities’
in current UK parlance). The representativeness of
the samples of participants is unknown (and there are
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no reliable data across the United Kingdom to make
these comparisons). Although both samples were di-
verse in terms of gender, age, country and living sit-
uation, there were small numbers of people from any
minority ethnic communities (5% in Cohort 1; 6% in
Cohort 2). Reliable data on the ethnicity of adults
with ID across the United Kingdom is surprisingly
lacking; the 2011Census for the population as a whole
reported 12% of adults aged 18+ from minority ethnic
communities in England and Wales (ONS 2018); 4%
for adults aged 16+ in Scotland (National Records of
Scotland n.d.) and 2% for people of all ages in
Northern Ireland (Northern Ireland Statistics and
Research Agency 2016).
As the data are cross-sectional, we did not think it
appropriate to build regression models examining the
independent contribution of different correlates of
vaccine willingness. This may be important in future.
However, at this stage and to provide as much detail
to policy makers and public health practitioners as
possible, we focused on individual associations with
appropriate effect size measures so that readers and
organisations can independently assess the value of
different correlates identified in the current study.
We suggest that these first data on vaccine
willingness in adults with ID may be useful to inform
public health efforts. In particular, subgroups less
willing to accept COVID-19 vaccines could be the
focus of educational interventions especially if these
can be informed by additional research to understand
hesitancy in some sub-groups. Given that adults with
ID reported using television broadcasts as a main
source of information about COVID-19 (Flynn
et al. 2021) and that accessing information from the
television was also associated with increased vaccine
willingness, vaccine information targeted at (or made
appropriately accessible for) adults with ID via
television broadcasts may be particularly useful,
compared with the current focus on producing
easier-to-read web resources. In terms of adjustments
that should be made in vaccine programmes, our
findings also suggest that experience with vaccines
(or perhaps other preparation to increase familiarity
with/reduce anxiety about the vaccination procedure)
may be crucial for some adults with ID – making
reasonable adjustments at all stages to improve the
likelihood of people being vaccinated is likely to be
crucial in maximising vaccination rates (Rotenberg
et al. 2021).
Given the variation in COVID-19 vaccine
willingness around the world, variability in predictors
of willingness in different countries, and the lack of
data on vaccine willingness among people with ID,
more research, allied to urgent action, is clearly
needed.
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